Tay Sachs gene therapy (INSERM)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameTay Sachs gene therapy (INSERM)
Drug Alias NameG.HEXA vector (INSERM)
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Retroviral vector
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsMetabolic Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesInserm
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesInserm
Active IndicationsN/A
Inactive IndicationsMetabolic Diseases

Other Information

ATC CodeN/A
Related LinksN/A